Key Competitors Riding on Core Biotech Strengths

Key competitors are riding on their core biotech strengths and expanding their biotech API capabilities, says RNCOS in its latest research report.

Noida, India (prHWY.com) November 22, 2012 - According to a new research report by RNCOS entitled, "Global Biotech API Market Analysis", several key competitors are riding on their core biotech strengths and expanding their biotech API capabilities. Players, such as Bayer Pharma AG, Biocon Limited, Boehringer Ingelheim, Hospira amongst others are leading the biotech API market. Innovation and active R&D have become more robust in the industry and strategic activities through mergers and collaborations are growing in the market.

Although the biotech API market represents a small share in the overall API industry, its growth prospects are huge owing to the widespread applications in several therapeutic areas. And with the growing importance of biological drugs in the market, bioteches APIs are expected to account for a much higher share in the future in the overall API market. China and India are emerging as global superpowers in the API industry. The availability of cheap resources, such as infrastructure, labor, raw materials, etc accompanied by the advancing pharma expertise is one of the key factors backing this growth. Moreover, according to the latest report by RNCOS, the biotech API market is expected to grow at a CAGR of around 15% from 2012-2015.

The report, spread in over 55 pages provides an analysis of the global API and biotech API market. It provides a global break up of branded and generic API's and synthetic and biotech API's. Further, the biotech API market has been covered along with its major market segments. The geographic break-up provides an analysis on major geographies and untapped markets. The current and future forecasts for the API market have been presented to provide the market progress in the coming years along with expected growth in the overall industry. Regulatory scenario analysis has also been provided for a holistic understanding of the industry requirements. Major focus has been laid on the key competitor assessment to present a meaningful description of the biotech API business along with an analysis on their strengths and weaknesses.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM424.htm

Some of our Related Reports are:

- Interferon Market Forecast to 2015 (http://www.rncos.com/Report/IM431.htm)
- Insulin Market Forecast to 2015 (http://www.rncos.com/Report/IM430.htm)
- Human Growth Hormone Market Forecast to 2015 (http://www.rncos.com/Report/IM429.htm)
- Erythropoietin Market Forecast to 2015 (http://www.rncos.com/Report/IM428.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: biotech api market

Categories: Biotech

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code